SEC Filings TLDR

BlackRock, Inc. has filed an amendment to its Schedule 13G/A, disclosing an increased ownership in Ocular Therapeutix, Inc. As of September 30, 2025, BlackRock, Inc. beneficially owns 10,170,232 shares of common stock, representing a 5.8% ownership stake. This marks a significant increase from previous filings, with th...

BlackRock, Inc. has filed a Schedule 13G/A amendment indicating a reduction in its ownership stake in Nkarta, Inc. to 4.96%. The filing shows that BlackRock now holds 3,524,322 shares of Nkarta's common stock, down from 10,603,782 shares previously. This represents a 66.76% decrease in both the number of shares and the...

BlackRock, Inc. has filed a Schedule 13G/A amendment, disclosing an increased ownership of 14.8% in NETSCOUT SYSTEMS INC. The filing indicates that BlackRock now beneficially owns 10,603,782 shares of common stock, up from a previous holding. The shares are held through various business units of BlackRock, and the fili...

BlackRock, Inc. has filed an amendment to its Schedule 13G for NB BANCORP INC, reflecting changes in its ownership of the company's common stock. As of the effective date of October 17, 2025, BlackRock, Inc. beneficially owns 2,663,833 shares, representing 6.7% of the outstanding common stock. This marks a significant ...

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing an increased ownership in National Vision Holdings Inc. As of September 30, 2025, BlackRock, Inc. beneficially owns 11,378,890 shares of common stock, representing 14.4% of the total outstanding shares. This marks an increase of 1,120,085 shares fro...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing an increased ownership in NCR ATLEOS CORP. As of September 30, 2025, BlackRock beneficially owns 10,258,805 shares of NCR ATLEOS CORP's common stock, representing 13.9% of the total outstanding shares. This marks a significant increase from p...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for Mission Produce, Inc., reflecting changes in its beneficial ownership. As of September 30, 2025, BlackRock, Inc. holds 3,274,562 shares of common stock, representing 4.6% ownership. This is a significant decrease from its previous holdings, with a value c...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing an increased ownership in Medical Properties Trust Inc. As of September 30, 2025, BlackRock beneficially owns 69,021,718 shares of common stock, representing 11.5% of the total outstanding shares. This marks a significant increase from previo...

BlackRock, Inc. has filed a Schedule 13G/A amendment, disclosing an increased ownership in Marriott Vacations Worldwide Corp. As of the effective date of October 17, 2025, BlackRock, Inc. holds 3,366,770 shares, representing a 9.7% ownership stake in the company. This marks a significant increase from their previous ho...

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a reduction in its ownership of MarketAxess Holdings Inc. As of September 30, 2025, BlackRock owns 1,572,513 shares, representing 4.2% of the outstanding common stock. This marks a significant decrease from its previous holdings, with a reduction of...

BlackRock, Inc. has filed a Schedule 13G/A amendment, disclosing an increased ownership of 5.9% in Maravai LifeSciences Holdings, Inc. The filing indicates that BlackRock now holds 8,580,553 shares, a significant increase from previous holdings. The shares are held in the ordinary course of business and not for the pur...

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a reduction in its ownership of MAMAS CREATIONS INC's common stock. As of September 30, 2025, BlackRock owns 1,920,649 shares, representing 4.7% of the total outstanding shares. This marks a significant decrease from its previous holdings, with a red...

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing an increased ownership in MACOM Technology Solutions Holdings Inc. As of September 30, 2025, BlackRock holds 6,742,929 shares, representing 9.1% of the outstanding common stock. This marks an increase of 855,266 shares, or 14.5264%, from the previou...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing an increased ownership in MKS Instruments Inc. As of September 30, 2025, BlackRock beneficially owns 5,887,663 shares of MKS Instruments' common stock, representing an 8.8% ownership stake. This marks an increase of 271,425 shares from their ...

BlackRock, Inc. has filed a Schedule 13G/A amendment, disclosing an increased ownership in MGE Energy Inc. The filing reveals that BlackRock now holds 5,616,238 shares of MGE Energy's common stock, representing a 15.4% ownership stake. This marks a significant increase from previous holdings, with a value change of $4,...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing a reduction in its ownership of Lexeo Therapeutics, Inc. common stock. As of September 30, 2025, BlackRock owns 2,168,444 shares, representing a 4.0% ownership stake. This marks a significant decrease from its previous holdings, with a value ...

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing an increased ownership stake in Kratos Defense & Security Solutions, Inc. As of September 30, 2025, BlackRock owns 21,491,945 shares of common stock, representing a 12.7% ownership in the company. This marks a significant increase from previous fili...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing an increased ownership stake in Kearny Financial Corp. As of September 30, 2025, BlackRock beneficially owns 4,232,052 shares of Kearny Financial Corp's common stock, representing 6.5% of the total outstanding shares. This marks a significant...

BlackRock, Inc. has filed an amendment to its Schedule 13G for the iShares Top 20 U.S. Stocks ETF, reflecting changes in its beneficial ownership. As of September 30, 2025, BlackRock, Inc. beneficially owns 502,738 shares of the ETF, representing 4.5% of the total outstanding common shares. This is a decrease of 35,779...

BlackRock, Inc. has filed an amendment to its Schedule 13G for the iShares Nasdaq Top 30 Stocks ETF, reflecting changes in its beneficial ownership. The filing indicates that BlackRock, Inc. owns 538,517 shares, representing 8.6% of the total outstanding common stock. The shares are held solely by BlackRock, Inc., with...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing an increase in its ownership of Interactive Brokers Group Inc. Class A Stock. As of the effective date of October 17, 2025, BlackRock, Inc. beneficially owns 27,619,620 shares, representing 6.2% of the total outstanding shares. This marks a s...

BlackRock, Inc. has filed a Schedule 13G/A amendment, disclosing an increased ownership in Insight Enterprises Inc. As of September 30, 2025, BlackRock beneficially owns 4,415,847 shares of Insight Enterprises' common stock, representing 14% of the total outstanding shares. This marks a significant increase from previo...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A, reporting a decrease in its ownership of Inhibrx Biosciences, Inc. common stock. As of September 30, 2025, BlackRock owns 680,368 shares, representing 4.7% of the total outstanding shares. This marks a significant decrease from its previous holdings, with a ...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing a reduction in its ownership of INCYTE CORPORATION's common stock. As of September 30, 2025, BlackRock owns 15,242,171 shares, representing a 7.8% ownership stake. This marks a significant decrease from its previous holdings, with a reduction...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A, disclosing an increase in its ownership of Host Hotels and Resorts Inc. common stock. As of September 30, 2025, BlackRock beneficially owns 62,535,475 shares, representing 9.1% of the outstanding common stock. This marks a significant increase from previous ...